Search

everythinglearnresearchcommunity

for

Search:↓

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Cocaine possibly mixed with levamisole caused a woman's skin condition and blood issues, which improved with treatment.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Clofazimine may be effective for treating ashy dermatosis.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

MK-5108 is safe and shows potential against tumors, especially alone.

S-equol supplements significantly reduced menopausal symptoms in most women.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Promising cancer treatments were found, but the manufacturer closed.

New technologies improve diagnosis and treatment of digestive disorders.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Oregano extract helps fix testis and sperm damage caused by finasteride.

The girl had a rare disorder causing mental and physical symptoms, with weak hair and unclear neurological issues.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.